Be The First To
Santarus is a bit controlling, but in this case it's okay. Santarus' flagship drug Glumetza improves glycemic control for type 2 diabetes patients and is marketed through a partnership with Depomed. It markets a similar drug, Cycloset, also to improve glycemic control for type 2 diabetes, through a distribution and license agreement with S2 Therapeutics and Veroscience. Santarus' lead product used to be Zegerid, a modified version of omeprazole, the proton pump inhibitor found in AstraZeneca's best-selling Prilosec for heartburn. But when Zegerid's patent ran out and its...
This is the employer's chance to tell you why you should work for them. The information provided is from their perspective.
Employees are “Satisfied” 12 ratings
82% of the CEO 9 ratings
Gerald T. Proehl
President, CEO, and Director
Accepted Offer – Reviewed Jan 16, 2014
Interview Details Phone interview with local inVentiv recruiter, phone interview with hiring District Sales Manager, face to face interview with Regional Sales Director, hiring District Sales Manager, and inVentiv ERM. – Full Interview
Give me a growth opportunity for you? – Answer Question
Let us know if we're missing any workplace or industry recognition –